Navigation Links
Bioniche Reports Fiscal 2008 Second Quarter
Date:2/8/2008

------------------------------------------------------------------

Cash used in

operating

activities (4,501,383) (1,874,792) (7,163,380) (3,293,553)

-------------------------------------------------------------------------

INVESTING ACTIVITIES

Proceeds from

maturity of

short-term

investments - - 9,500,000 -

Proceeds from

sale of investment - 3,196,200 - 3,196,200

Proceeds from sale

of right to future

royalty stream - 3,652,800 - 3,652,800

Government incentives

received on account

of property, plant

and equipment 2,807 30,224 4,641 30,224

Purchase of property,

plant and equipment (73,688) (74,671) (272,397) (182,076)

-------------------------------------------------------------------------

Cash provided by

(used in) investing

activities (70,881) 6,804,553 9,232,244 6,697,148

-------------------------------------------------------------------------

FINANCING ACTIVITIES

Proceeds from

deferred government

incentives 18,701 74,282 49,965 74,282

Proceeds from

revolving credit

facility 8,505,017 5,560,270 13,451,976 10,052,318

Repayment of

revolving credit

facility (5,281,835) (5,548,157) (10,380,520) (10,705,685)

Repayment of

obligations under

capital lease (29,164) (25,584) (64,323) (58,259)

Repayment of senior

and other long-term

debt (4,861) (2,956,883) (9,612) (3,234,149)

-------------------------------------------------------------------------

Cash provided by

(used in) financing<
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. Bioniche Reports Fiscal 2008 First Quarter
8. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
9. Bioniche Amends Terms of Convertible Debt with Laurus Master Funds
10. USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine
11. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... As the use of electronic health record becomes widespread ... implementation of the Affordable Care Act, the quantity of ... analytic purposes will also dramatically increase. Additionally, experts ... that analyze large quantities of data for the purpose ... the value of patient care a process that ...
(Date:7/10/2014)... THURSDAY, July 10, 2014 (HealthDay News) -- Teens who ... are more likely to develop emotional symptoms such as ... factors such as these that may exacerbate issues teens ... appropriate treatment and in making decisions about when to ... school for these athletes," study authors Lisa Koehl and ...
(Date:7/10/2014)... Thompson HealthDay Reporter THURSDAY, ... 10 adults make use of calorie information on menus, if ... to a new U.S. study. Women in particular review ... Lee-Kwan, an epidemiologist with the U.S. Centers for Disease Control ... used menu labeling to help choose their meal, compared with ...
(Date:7/10/2014)... device developed at the Massachusetts General Hospital (MGH) Center ... can be cultured to establish cell lines for genetic ... issue of Science , an MGH research team ... genetic mutation over time and changing susceptibility to therapeutic ... the blood that represent those present in metastatic deposits, ...
(Date:7/10/2014)... CLEVELAND The U.S. Department of Health and Human ... Hospitals (UH) Case Medical Center Seidman Cancer Center totaling ... at improving care for patients with complex cancer. ... a unique model developed at UH to enhance care ... or demonstrated need for high health care utilization. ...
Breaking Medicine News(10 mins):Health News:Six cases where big data can reduce healthcare costs 2Health News:Six cases where big data can reduce healthcare costs 3Health News:Six cases where big data can reduce healthcare costs 4Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 2Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 3Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3
... 14 Senator McCain believes it to,be a responsibility; ... reform is a high priority, they disagree on the ... which plan physicians,support? A new study from DoctorDirectory of ... assess attitudes on universal healthcare as,it relates to the ...
... TMR,09 campaign, IRVINE, Calif., Oct. 14 ... leader of innovative therapies,for ischemic cardiac disease ... for,transmyocardial revascularization (TMR), sponsored an educational symposium,yesterday ... Cardiovascular,Therapeutics (TCT) meeting in Washington, D.C., ...
... Center,s quality awards rank its care among,the top ... 11th Annual Hospital Quality in,America Study, HOUSTON, ... that it has received the 2009 Specialty Excellence,Awards ... HealthGrades, a,leading independent healthcare ratings company. These awards ...
... customized recruitment leadership, training and outsourcing continues to show strong ... Praxair, Kronos, Roxanne, ABB, Siemens Candida and others. The ... provider on HRO Today’s annual Baker’s Dozen list. , ... ...
... leader in customized Market Intelligence and Strategic Analysis responds to customer ... Germany and Netherlands, giving the group 10 offices across three continents ... , ... Helsinki (PRWEB) October 14, 2008 -- Global ...
... 14 Researchers at the Institute,of Photonics, University ... year,project to develop a novel solid-state laser design ... Six Ltd.,Element Six leads the world in the ... The development of a diamond Raman laser could ...
Cached Medicine News:Health News:The Public Knows the Candidates' Views on Healthcare Reform, But Do the Candidates Know What Healthcare Professionals Think? 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Houston Northwest Medical Center Receives Clinical Excellence Awards for Several Service Lines 2Health News:Houston Northwest Medical Center Receives Clinical Excellence Awards for Several Service Lines 3Health News:The RightThing Continues Drive: Completes Strong Q3 2Health News:Global Intelligence Alliance Strengthens Group Organization and Adds Local Presence, Merges With Asian, German and Dutch Partner Companies 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
(Date:7/10/2014)... LAVAL, Quebec , July 10, 2014  Valeant ... TSX: VRX) today announced it has completed the sale ... Sculptra, and Dysport owned or held by Valeant for ... agreement with Nestle S.A, which recently completed its acquisition ... complete the divestiture of our products to a company ...
(Date:7/10/2014)... BURLINGTON, Mass. , July 10, 2014 ... nephrologists report awareness of the U.S. Food and Drug ... Pharma,s new phosphate binder Velphoro, which was approved by ... hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis. ... TreatmentTrends: Nephrology (US) Q2 2014 ...
(Date:1/15/2014)... 15, 2014 As health officials across the Midwest warn ... pharmacies in Michigan will offer free ... enabling Meijer pharmacists to administer tests and, in some cases, ... physician participating in the study. The ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
... , , , , , SAN ... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ), Eli Lilly and ... ALKS ) today announced positive results from a head-to-head ... BYETTA® (exenatide) injection taken twice daily, in patients with type ...
... , , LONDON, Dec. 14 The 2009 Frost ... Market is conferred on SonoScape. The award recipient has effectively ... pricing, and portability - and introduced the S8 hand-carried ultrasound ... compares with that of a regular, high-end, cart-based echo ultrasound ...
Cached Medicine Technology:Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: